This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: The Brigham and Women's Hospital, Inc., The Broad Institute, Inc.. Active years: 2018-2023.
Company Filing History:


Years Active: 2018-2023
Title: Emma Fink: Innovator in Disease Biomarkers and Treatment Methods
Introduction
Emma Fink is a prominent inventor based in Boston, MA, known for her significant contributions to the field of biomedical research. With a focus on disease biomarkers and treatment methods, she has developed innovative solutions that have the potential to impact patient care and therapeutic strategies. Emma holds a total of 3 patents, showcasing her dedication to advancing medical science.
Latest Patents
Among her latest patents, Emma has developed groundbreaking technologies, including a knock-in mouse model featuring a mutation in an endogenous CRBN locus. This invention provides valuable insights into disease mechanisms and potential treatment pathways. Additionally, she has created IMiD screening methods utilizing IMiD-sensitive cells with mutant CRBN, further enhancing the understanding of drug interactions and efficacy.
Career Highlights
Emma has worked with esteemed organizations such as the Broad Institute, Inc. and Brigham and Women's Hospital, Inc. These institutions have provided her with a platform to collaborate with leading researchers and contribute to cutting-edge projects in the biomedical field. Her work has not only advanced scientific knowledge but has also paved the way for new therapeutic approaches.
Collaborations
Emma has collaborated with notable colleagues, including Benjamin L. Ebert and Jan Krönke. These partnerships have enriched her research and fostered a collaborative environment that encourages innovation and discovery.
Conclusion
Emma Fink's contributions to the field of disease biomarkers and treatment methods exemplify her commitment to advancing medical research. Her innovative patents and collaborations with leading institutions highlight her role as a key figure in the scientific community. Emma continues to inspire future generations of inventors and researchers through her work.